24 jan 2018 ano - FDA and the Federal Trade Commission posted joint warning letters to the marketers and distributors of 12 opioid cessation products, for illegally marketing unapproved products with claims about their ability to help in the treatment of opioid addiction and withdrawal.

Adicionado na linha do tempo:

Opioids and the FDA

ByAnastasia

13 nov 2018

0 0 330

Data: